Urinary cytology for the detection of urothelial carcinoma of the bladder--a flawed adjunct to cystoscopy?

[1]  U. Capitanio,et al.  Erratum: Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection (BJU International (2009) 103 (1368-1374)) , 2010 .

[2]  U. Capitanio,et al.  Impact of clinical factors, including a point‐of‐care nuclear matrix protein‐22 assay and cytology, on bladder cancer detection , 2009, BJU international.

[3]  J. Witjes,et al.  Urinary markers in bladder cancer. , 2008, European urology.

[4]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[5]  K. Sethia,et al.  Is routine urine cytology useful in the haematuria clinic? , 2008, Annals of the Royal College of Surgeons of England.

[6]  A. Agarwal,et al.  Voided urinary cytology in bladder cancer: is it time to review the indications? , 2007, Urology.

[7]  S. Johansson,et al.  Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria. , 2006, The Journal of urology.

[8]  A. Sagalowsky,et al.  Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder , 2006, BJU international.

[9]  T. Kwast,et al.  Urine markers for bladder cancer surveillance: a systematic review. , 2005 .

[10]  Yair Lotan,et al.  Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder. , 2005, The Journal of urology.

[11]  G. Nabi,et al.  How important is urinary cytology in the diagnosis of urological malignancies? , 2003, European urology.

[12]  T. Tammela,et al.  Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis. , 2002, European urology.

[13]  R. Chahal,et al.  Is It Necessary to Perform Urine Cytology in Screening Patients with Haematuria? , 2001, European Urology.

[14]  D J O'Kane,et al.  A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. , 2000, The Journal of urology.

[15]  W. Murphy,et al.  Monitoring patients for bladder neoplasms: what can be expected of urinary cytology consultations in clinical practice. , 1999, Urology.

[16]  M. Luján,et al.  Reliability of the Routine Cytological Diagnosis in Bladder Cancer , 1999, European Urology.

[17]  M. Cohen,et al.  Low-grade transitional cell carcinoma of the urinary bladder: application of select cytologic criteria to improve diagnostic accuracy [corrected]. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[18]  G. Vooijs,et al.  Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. , 1993, Acta cytologica.

[19]  W. Murphy.  Current status of urinary cytology in the evaluation of bladder neoplasms. , 1990, Human pathology.

[20]  L. Koss,et al.  Interobserver and intraobserver differences in the diagnosis of urothelial cells. Comparison with classification by computer. , 1984, Analytical and quantitative cytology.

[21]  Yair Lotan,et al.  Critical evaluation of urinary markers for bladder cancer detection and monitoring. , 2008, Reviews in urology.

[22]  C. Roehrborn,et al.  Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. , 2003, Urology.